| Mr Jason Anthony Albano, PSYD | |
|
7603 Nw Taylor Ave, Lawton, OK 73505-2430 | |
| (417) 425-9465 | |
| Not Available |
| Full Name | Mr Jason Anthony Albano |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 7603 Nw Taylor Ave, Lawton, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053598987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 2006028786 (Missouri) | Secondary |
| 103T00000X | Psychologist | 0810004447 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jason Anthony Albano, PSYD 7603 Nw Taylor Ave, Lawton, OK 73505-2430 Ph: (417) 425-9465 | Mr Jason Anthony Albano, PSYD 7603 Nw Taylor Ave, Lawton, OK 73505-2430 Ph: (417) 425-9465 |
News Archive
These days, most health warnings about vitamins focus on the danger of overdose. For vitamin B12, though, it's more likely that people are getting too little. In fact, B12 deficiency is the most common nutritional deficiency in the developing world and possibly in the United States as well, reports the August issue of the Harvard Health Letter.
It is known that sleep facilitates the formation of long-term memory in humans. In a new study, researchers from Uppsala University, Sweden, now show that sleep does not only help form long-term memory but also ensures access to it during times of cognitive stress.
Ipsen today announced new governance in the United States, following its recently announced decision to launch Somatuline for oncology indications. Marc de Garidel will personally oversee this projected launch.
GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.
Novavax, Inc. announced today that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects.
› Verified 2 days ago